SBS
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001 (NCT02246816) | Marathon Pharmaceuticals, LLC | 2015-02-01 |
| A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals (NCT02242656) | Marathon Pharmaceuticals, LLC | 2014-12-01 |
Track SBS automatically
Every clearance here is in the API, with alerts when new ones post.